Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
Pfizer Divests $3.3B Stake In Sensodyne Toothpaste And Panadol Painkiller Maker Haleon
The U.S. drug giant had initially planned to sell about 540 million shares but increased this to 640 million due to strong demand, a book-runner on the deal stated. Haleon confirmed it will repurchase approximately 60.5 million of its shares from Pfizer for 230 million pounds ($307.4 million).Pfizer Inc. (NYSE:PFE) has divested a $3.3 billion stake in Haleon (NYSE:HLN), reducing its holding in the British consumer healthcare company.
輝瑞股份有限公司（紐交所:PFE）已經將33億美元的股份在Haleon（紐交所:HLN）中出售，將其持有的英國消費保健公司的股份減少。
What Happened: The transaction occurred on Monday, cutting Pfizer's shareholding from 22.6% to 15%. The shares were sold at 380 pence each, a 3.3% discount to Haleon's last closing price.
事情經過：交易發生在星期一，將輝瑞的參股比例從22.6%降至15%。每股售價爲380便士，比Haleon上次收盤價低3.3%。
Haleon, known for products like Sensodyne toothpaste and Panadol painkillers, saw its shares drop 1.2% to 388 pence in Tuesday morning trade. Despite the sale, Pfizer remains Haleon's largest shareholder.
Haleon以Sensodyne牙膏和Panadol止痛藥等產品而聞名，週二上午交易時，其股價下跌1.2%至388便士。儘管賣出，輝瑞仍然是Haleon最大的股東。
The U.S. drug giant had initially planned to sell about 540 million shares but increased this to 640 million due to strong demand, a book-runner on the deal stated. Haleon confirmed it will repurchase approximately 60.5 million of its shares from Pfizer for 230 million pounds ($307.4 million).
這家美國藥品巨頭最初計劃出售約54000萬股，但由於強勁需求增至64000萬股，交易主承銷商表示。Haleon確認將從輝瑞手中回購約6050萬股，價格爲2.3億英鎊（30740萬美元）。
Why It Matters: This divestment comes on the heels of Pfizer's recent challenges.
爲什麼重要：這一出售發生在輝瑞最近面臨挑戰之際。
On Thursday, Pfizer announced the voluntary withdrawal of its sickle cell disease treatment Oxbryta (voxelotor) from the global market due to severe complications and deaths. This decision also included halting all active clinical trials and expanding access programs for the drug.
上週四，輝瑞宣佈自願將其鐮刀形紅細胞病治療藥物Oxbryta（體積奧拜卡）從全球市場撤出，因嚴重併發症和死亡。該決定還包括停止所有臨床試驗和擴大該藥物的使用計劃。
Price Action: Pfizer Inc. stock closed at $28.94 on Monday, down 0.52% for the day, and is currently trading at $29.01 in pre-market, reflecting a slight gain of 0.24%. Year-to-date, Pfizer's stock has declined by 2.66%.
股價走勢：輝瑞股份有限公司週一收盤價爲28.94美元，下跌了0.52%，目前在盤前交易中以29.01美元交易，反映出輕微的增長0.24%。截至目前，輝瑞的股價已下跌了2.66%。
Meanwhile, Haleon PLC – ADR finished at $10.58, down 0.84% on the same day, with a pre-market price up by 0.19%. The stock has performed well this year, rising by 28.55%, according to data from Benzinga Pro.
與此同時，Haleon PLC – ADR在同一天收盤價爲10.58美元，下跌了0.84%，盤前價格上漲了0.19%。根據Benzinga Pro的數據顯示，該股今年表現不錯，漲幅爲28.55%。
- Nvidia Stock Could Touch $800 By 2030, BGG Executive Predicts 550% Upside Driven By AI Revolution And Web3 Transition
- 英偉達股票可能在2030年觸及800美元，BGG高管預測550%的上升，這是由人工智能革命和Web3過渡推動的。
Image Via Shutterstock
圖片來自Shutterstock。
Disclaimer: This content was partially produced with the help of AI tools and was reviewed and published by Benzinga editors.
免責聲明：本內容部分使用人工智能工具生成，並經Benzinga編輯審核發佈。
譯文內容由第三人軟體翻譯。
